Ameritas Investment Company’s iBio IBIO Stock Holding History

Ameritas Investment Company’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	-$1K	–	898
2020 Q1	$1K	Buy	+3	New	+$1.16K	﹤0.01%	1656

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ameritas Investment Company's IBIO Position: Q2 2020 in Review

Ameritas Investment Company sold out of iBio (IBIO) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

Ameritas Investment Company first reported a position in IBIO in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 57 funds tracked by Wall St. Rank hold IBIO as of Q2 2020.

Ameritas Investment Company reported no remaining iBio position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Company sold 3 iBio shares in Q2 2020, an estimated $1K.
Ameritas Investment Company first reported a position in iBio in Q1 2020 and held it in 1 quarter.
Ameritas Investment Company's iBio position peaked at $1K in Q1 2020.
57 funds tracked by Wall St. Rank held iBio as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.